Cargando…

Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis

BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Andrea, Crump, John A, Kirk, Martyn, Glass, Kathryn, Howden, Benjamin, Gray, Darren, Furuya-Kanamori, Luis, Vilkins, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631758/
http://dx.doi.org/10.1093/ofid/ofx163.645
_version_ 1783269551552593920
author Parisi, Andrea
Crump, John A
Kirk, Martyn
Glass, Kathryn
Howden, Benjamin
Gray, Darren
Furuya-Kanamori, Luis
Vilkins, Samantha
author_facet Parisi, Andrea
Crump, John A
Kirk, Martyn
Glass, Kathryn
Howden, Benjamin
Gray, Darren
Furuya-Kanamori, Luis
Vilkins, Samantha
author_sort Parisi, Andrea
collection PubMed
description BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been systematically examined. We conducted a systematic review and meta-analysis to examine impacts of MDR NTS on disease outcomes in high-income settings. METHODS: We systematically reviewed the literature from scientific databases, including PubMed, Scopus and grey literature sources, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included case–control studies, cohorts, outbreaks, and theses, imposing no language restriction. We included only publications from 1 January 1990 through 15 September 2016 from high-income countries as classified by the World Bank, and extracted data on duration of illness, hospitalization, morbidity and mortality of MDR and susceptible NTS infections. RESULTS: After we removed duplicates, the initial search revealed 4 258 articles. After further screening, we identified 16 eligible studies for the systematic review, but due to inconsistency in the compared groups, only 9 of these were included in the meta-analysis. NTS serotypes differed among the reported studies but serotypes Typhimurium, Enteritidis, Newport, and Heidelberg were the most often reported MDR pathogens. Salmonella infections that were MDR were associated with excess bloodstream infections (OR 1·73; 95% CI 1·32–2·27), excess hospitalizations (OR 2·51; 95% CI 1·38–4·58), and higher mortality (OR 3·54; 95% CI 1·10–11·40). CONCLUSION: The results of this meta-analysis suggest that MDR NTS infections have more serious health outcomes compared with susceptible isolates. With the emergence of MDR Salmonella strains in high-income countries, it is crucial to restrict the use of antimicrobials in animals and humans, and intervene to prevent foodborne infections. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631758
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56317582017-11-07 Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis Parisi, Andrea Crump, John A Kirk, Martyn Glass, Kathryn Howden, Benjamin Gray, Darren Furuya-Kanamori, Luis Vilkins, Samantha Open Forum Infect Dis Abstracts BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been systematically examined. We conducted a systematic review and meta-analysis to examine impacts of MDR NTS on disease outcomes in high-income settings. METHODS: We systematically reviewed the literature from scientific databases, including PubMed, Scopus and grey literature sources, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included case–control studies, cohorts, outbreaks, and theses, imposing no language restriction. We included only publications from 1 January 1990 through 15 September 2016 from high-income countries as classified by the World Bank, and extracted data on duration of illness, hospitalization, morbidity and mortality of MDR and susceptible NTS infections. RESULTS: After we removed duplicates, the initial search revealed 4 258 articles. After further screening, we identified 16 eligible studies for the systematic review, but due to inconsistency in the compared groups, only 9 of these were included in the meta-analysis. NTS serotypes differed among the reported studies but serotypes Typhimurium, Enteritidis, Newport, and Heidelberg were the most often reported MDR pathogens. Salmonella infections that were MDR were associated with excess bloodstream infections (OR 1·73; 95% CI 1·32–2·27), excess hospitalizations (OR 2·51; 95% CI 1·38–4·58), and higher mortality (OR 3·54; 95% CI 1·10–11·40). CONCLUSION: The results of this meta-analysis suggest that MDR NTS infections have more serious health outcomes compared with susceptible isolates. With the emergence of MDR Salmonella strains in high-income countries, it is crucial to restrict the use of antimicrobials in animals and humans, and intervene to prevent foodborne infections. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631758/ http://dx.doi.org/10.1093/ofid/ofx163.645 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Parisi, Andrea
Crump, John A
Kirk, Martyn
Glass, Kathryn
Howden, Benjamin
Gray, Darren
Furuya-Kanamori, Luis
Vilkins, Samantha
Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title_full Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title_fullStr Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title_full_unstemmed Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title_short Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
title_sort health outcomes from multi-drug-resistant salmonella infections in high-income countries: a systematic review and meta-analysis
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631758/
http://dx.doi.org/10.1093/ofid/ofx163.645
work_keys_str_mv AT parisiandrea healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT crumpjohna healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT kirkmartyn healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT glasskathryn healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT howdenbenjamin healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT graydarren healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT furuyakanamoriluis healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis
AT vilkinssamantha healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis